Human epidermal growth factor 2 negative carcinoma of breast (Disease Or Phenotype)

Medcin:MEDCIN:356910

Id:0833897c-67ca-5401-b6f4-dbfa610d16e6

Results found

Linked to

	Label	Description
	Palbociclib; Ibrance indication Human epidermal growth factor 2 negative carcinoma of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Abemaciclib indication Human epidermal growth factor 2 negative carcinoma of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one::Acylpiperazine analogue, 47::Olaparib::US9187430, AZD-2281::US9255106, AZD2281 indication Human epidermal growth factor 2 negative carcinoma of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Palbociclib; Ibrance indication Human epidermal growth factor 2 negative carcinoma of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Abemaciclib indication Human epidermal growth factor 2 negative carcinoma of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one::Acylpiperazine analogue, 47::Olaparib::US9187430, AZD-2281::US9255106, AZD2281 indication Human epidermal growth factor 2 negative carcinoma of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025